Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yasuhiko Yamanaka

Managing Director of Special Missions and Director, Takeda Pharmaceutical Company Limited
AgeTotal Calculated CompensationThis person is connected to 18 board members in 1 different organizations across 1 different industries.

See Board Relationships
--¥121,000,000
As of Fiscal Year 2014

Background*

Mr. Yasuhiko Yamanaka has been Managing Director of Special Missions of Takeda Pharmaceutical Company Limited since June 2014 and served as its Managing Director since June 2011. Mr. Yamanaka has been a Managing Director at Takeda Pharmaceuticals International, Inc. since June 24, 2011 and Assistant To Chief Executive Officer since April 1, 2012. Mr. Yamanaka served as Senior Vice President of Pharmaceutical Marketing Division and General Manager of Pharmaceutical Marketing ...

Read Full Background

Corporate Headquarters*

1-1, Doshomachi 4-chome
Osaka, -- 540-8645

Japan

Phone: 81 6 6204 2111
Fax: 81 6 6204 2880

Board Members Memberships*

2007-Present
Managing Director of Special Missions and Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary¥43,000,000
Bonus¥50,000,000
Total Annual Compensation¥93,000,000

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation¥93,000,000
Total Short Term Compensation¥93,000,000
Total Calculated Compensation¥121,000,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4502:JP ¥6,080.00 JPY -31.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vincent A. Forlenza BDChairman, Chief Executive Officer and President
Becton, Dickinson and Company
$985.0K
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
$1.1M
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€6.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.